Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.27 CAD | -4.22% | -8.10% | +440.48% |
05-13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
05-13 | Medicenna Brief: Providing Update on its Presentations at the 2024 ASCO Annual Meeting | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+440.48% | 125M | |
+41.34% | 50.93B | |
-0.38% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.14% | 26.02B | |
-22.07% | 18.9B | |
+8.15% | 13.21B | |
+24.20% | 12.17B | |
+30.51% | 12.16B |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- Medicenna on Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor; Chief Scientific Officer Departs